Sign Up Today and Learn More About Kromatid Stock
Invest in or calculate the value of your shares in Kromatid or other pre-IPO companies through EquityZen's platform.
Kromatid Stock (KROM)
KromaTiD focuses on advancing the knowledge of genetic abnormalities and diseases by developing molecular cytogenetics assays and reagents.
About Kromatid Stock
Founded
2007
Headquarters
Fort Collins, CO, US
Industries
Software, Artificial Intelligence, Data and Analytics
Kromatid Press Mentions
Stay in the know about the latest news on Kromatid
Methods, compositions, and kits for determining chromosome stability, …
patents • Apr 14, 2024
Methods for high resolution spectral chromosome banding to detect chromosomal …
patents • Apr 14, 2024
METHODS FOR ANALYZING CHROMOSOMES AND CHROMOSOMAL ABNORMALITIES USING dGH WITH …
patents • Apr 14, 2024
Stony Brook Study on the Role of DNA Amplification in Cancer Chemoresistance Leverages KromaTiD dGH in-Site ...
prnewswire • Apr 09, 2024
Base Editing Market is Expected to Reach $549 Million ...
globenewswire • Jan 31, 2024
Kromatid Management
Leadership team at Kromatid
Director
Walter Young
Member Board Of Directors
Priya Gogoi
Join now and verify your accreditation status to gain access to:
- Kromatid current valuation
- Kromatid stock price
- Available deals in Kromatid and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Kromatid stock?
Accredited investors can buy pre-IPO stock in companies like Kromatid through EquityZen funds. These investments are made available by existing Kromatid shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Kromatid stock?
Shareholders can sell their Kromatid stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
